Component

Chylomicron alpha-tocopherol stereoisomer delivery

Appearance of labeled alpha-tocopherol stereoisomers in the human chylomicron fraction.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. After equal oral labeled RRR- and SRR-alpha-tocopheryl acetate, the human chylomicron fraction contained similar concentrations of the two tocopherol stereoisomers.

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Human stable-isotope oral study with lipoprotein fractionation
    exposure
    Four subjects received equal paired doses of labeled RRR and SRR acetate ester with breakfast: 40, 50, 75 or 75 mg of each ester; samples through 76 hours.
    limitations
    Small tracer study; fraction enrichment alone does not prove the molecular sorting step or clinical benefit.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    Early chylomicron delivery did not strongly distinguish the two tested stereoisomers.
    primary_references
    [traber1990] RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. (1990). https://pubmed.ncbi.nlm.nih.gov/2351872/ DOI: 10.1016/s0022-2275(20)42836-6
    tissue_or_cell_type
    Plasma chylomicron or VLDL fractions

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 298–309

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human stable-isotope oral study with lipoprotein fractionation · source_derived_draft · unverified_draft

    ### ve-transport-chylomicron-stereoisomers After equal oral labeled RRR- and SRR-alpha-tocopheryl acetate, the human chylomicron fraction contained similar concentrations of the two tocopherol stereoisomers. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Early chylomicron delivery did not strongly distinguish the two tested stereoisomers. organism: Homo sapiens tissue_or_cell_type: Plasma chylomicron or VLDL fractions experimental_model: Human stable-isotope oral study with lipoprotein fractionation limitations: Small tracer study; fraction enrichment alone does not prove the molecular sorting step or clinical benefit. exposure: Four subjects received equal paired doses of labeled RRR and SRR acetate ester with breakfast: 40, 50, 75 or 75 mg of each ester; samples through 76 hours. cross_nutrient: false [traber1990] RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. (1990). https://pubmed.ncbi.nlm.nih.gov/2351872/ DOI: 10.1016/s0022-2275(20)42836-6
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards